Pages that link to "Q47927665"
Jump to navigation
Jump to search
The following pages link to Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD: a pilot study (Q47927665):
Displaying 50 items.
- Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring (Q26778684) (← links)
- Animal models of COPD: What do they tell us? (Q28066451) (← links)
- Therapeutic Potential of Medicinal Plants and Their Constituents on Lung Inflammatory Disorders (Q28067576) (← links)
- Elimination mechanisms of therapeutic monoclonal antibodies (Q28297407) (← links)
- Toxicological protein biomarker analysis--an investigative one-week single dose intravenous infusion toxicity and toxicokinetic study in cynomolgus monkeys using an antibody-cytotoxic conjugate against ovarian cancer (Q33308781) (← links)
- Cytokine inhibition in the treatment of COPD. (Q33568552) (← links)
- Chronic obstructive pulmonary disease: towards pharmacogenetics (Q33600138) (← links)
- Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production (Q33898616) (← links)
- Angiogenesis and progression in human melanoma. (Q33982978) (← links)
- Application of quantitative pharmacology in development of therapeutic monoclonal antibodies (Q34293689) (← links)
- Smoking cessation therapy with varenicline (Q34805380) (← links)
- Update on Pharmaceutical and Minimally Invasive Management Strategies for Chronic Obstructive Pulmonary Disease (Q35028812) (← links)
- Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer (Q35897669) (← links)
- Therapeutic effects of LASSBio-596 in an elastase-induced mouse model of emphysema (Q36105708) (← links)
- Molecular targets in the treatment of alcoholic hepatitis (Q36351877) (← links)
- Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma? (Q36376519) (← links)
- Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD. (Q36426923) (← links)
- Angiogenesis in melanoma (Q36626892) (← links)
- Chemokines and their receptors in respiratory disease: a therapeutic target for respiratory syncytial virus infection. (Q36839725) (← links)
- Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease (Q36956720) (← links)
- Biological targets for therapeutic interventions in COPD: clinical potential (Q37018843) (← links)
- Host defenses against respiratory tract infection: implications for anti-inflammatory drug development and treatment (Q37030665) (← links)
- Dexamethasone for Dyspnea in Cancer Patients: A Pilot Double-Blind, Randomized, Controlled Trial (Q37120940) (← links)
- Club Cell Protein 16 (CC16) Augmentation: A Potential Disease-modifying Approach for Chronic Obstructive Pulmonary Disease (COPD) (Q37158751) (← links)
- Moving targets: cell migration inhibitors as new anti-inflammatory therapies (Q37246694) (← links)
- Attacking the multi-tiered proteolytic pathology of COPD: new insights from basic and translational studies (Q37332258) (← links)
- Targeted treatment in COPD: a multi-system approach for a multi-system disease (Q37340178) (← links)
- Chemokines and their receptors: orchestrating a fine balance between health and disease (Q37603336) (← links)
- Anti-chemokine small molecule drugs: a promising future? (Q37683772) (← links)
- Platelet-derived chemokines: pathophysiology and therapeutic aspects (Q37705023) (← links)
- Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease (Q37836078) (← links)
- Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic drug resistance? (Q37846342) (← links)
- Chemokines as targets for therapy (Q37849900) (← links)
- Understanding mechanisms and documenting plausibility of palliative interventions for dyspnea (Q37856687) (← links)
- The future of chronic obstructive pulmonary disease treatment—difficulties of and barriers to drug development (Q37930205) (← links)
- Chemokines: established and novel targets in atherosclerosis (Q37950973) (← links)
- Emerging drugs for chronic obstructive pulmonary disease. (Q37984088) (← links)
- Targeting interleukins to treat severe asthma (Q38042721) (← links)
- Monoclonal antibodies for asthma and chronic obstructive pulmonary disease (Q38071124) (← links)
- New anti-inflammatory targets for chronic obstructive pulmonary disease. (Q38131512) (← links)
- Neutrophils and emerging targets for treatment in chronic obstructive pulmonary disease. (Q38156225) (← links)
- Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer. (Q38166232) (← links)
- Anti-interleukin therapy in asthma (Q38351475) (← links)
- Angiogenesis in melanoma: an update with a focus on current targeted therapies (Q38729125) (← links)
- Chronic inflammatory airway diseases: the central role of the epithelium revisited (Q38791607) (← links)
- Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease. (Q38923185) (← links)
- Andrographolide antagonizes cigarette smoke extract-induced inflammatory response and oxidative stress in human alveolar epithelial A549 cells through induction of microRNA-218. (Q39050559) (← links)
- Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases (Q39321350) (← links)
- Local delivery of siRNA-loaded calcium phosphate nanoparticles abates pulmonary inflammation (Q40096820) (← links)
- From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice (Q40166479) (← links)